IS:IPCALAB Ipca Laboratories Limited

Ipca Laboratories Limited manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, anthelmintic, and nonsteroidal anti-inflammatory drugs. It also provides generic and branded formulations in various dosage forms, such as oral solids and liquids, dry powders for suspension, and liquid and dry injectables. The company offers formulations in the therapeutic segments comprising anti-diabetic, anti-infectives, anti-malarials, anti-parasitic, hemostatic, cardiac, DMARDs, derma, gastro intestinal, urologicals, hepatoprotectives, steroid, biologicals, neuro psychiatry, opthalmology, pain, respiratory, and anti allergic, as well as nutritionals. In addition, it provides drug intermediates. The company markets its products through a network of wholesalers, and sales and marketing personnel. Ipca Laboratories Limited also exports its products to approximately 120 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

1,043.20 INR
As of 01/25/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  12/31/1999
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   264,990,507,008 INR
Current dividend yield:   0.76%
Sedol:      6433473

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy